Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance

Por Pang, Lisa Y., Saunders, Lauren, Argyle, David J.
Publicado no Oncotarget (2017)

Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy

Por Pang, Lisa Y., Hurst, Emma A., Argyle, David J.
Publicado no Stem Cells Int (2016)

The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention

Por Chen, Yu-Ting, Tan, Karen AL, Pang, Lisa Y, Argyle, David J
Publicado em 2012

Canine Mammary Cancer Stem Cells are Radio- and Chemo-Resistant and Exhibit an Epithelial-Mesenchymal Transition Phenotype

Por Pang, Lisa Y., Cervantes-Arias, Alejandro, Else, Rod W., Argyle, David J.
Publicado em 2011

Canine mammary cancer cells direct macrophages toward an intermediate activation state between M1/M2

Por Beirão, Breno C.B., Raposo, Teresa, Pang, Lisa Y., Argyle, David J.
Publicado no BMC Vet Res (2015)

The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro

Por Pang, Lisa Y, Argyle, Sally A, Kamida, Ayako, Morrison, Katherine O’Neill, Argyle, David J
Publicado em 2014

Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation

Por Pang, Lisa Y., Gatenby, Emma L., Kamida, Ayako, Whitelaw, Bruce A., Hupp, Ted R., Argyle, David J.
Publicado em 2014